Drug manufacturers must advise health care providers about risks a drug may present to a patient’s close contacts, a Staten Island Supreme Court justice has ruled in a case of first impression for New York state courts.
Justice William F. Mastro adopted a recent recommendation contained in the Restatement (Third) of Torts in a case where the father of a child being vaccinated against polio contracted paralytic poliomyelitis.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]